Unknown

Dataset Information

0

Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands.

ABSTRACT: The D2 dopamine receptor (DRD2) is one of the most well-established therapeutic targets for neuropsychiatric and endocrine disorders. Most clinically approved and investigational drugs that target this receptor are known to be subfamily-selective for all three D2-like receptors, rather than subtype-selective for only DRD2. Here, we report the crystal structure of DRD2 bound to the most commonly used antipsychotic drug, haloperidol. The structures suggest an extended binding pocket for DRD2 that distinguishes it from other D2-like subtypes. A detailed analysis of the structures illuminates key structural determinants essential for DRD2 activation and subtype selectivity. A structure-based and mechanism-driven screening combined with a lead optimization approach yield DRD2 highly selective agonists, which could be used as chemical probes for studying the physiological and pathological functions of DRD2 as well as promising therapeutic leads devoid of promiscuity.

SUBMITTER: Fan L 

PROVIDER: S-EPMC7044277 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Haloperidol bound D<sub>2</sub> dopamine receptor structure inspired the discovery of subtype selective ligands.

Fan Luyu L   Tan Liang L   Chen Zhangcheng Z   Qi Jianzhong J   Nie Fen F   Luo Zhipu Z   Cheng Jianjun J   Wang Sheng S  

Nature communications 20200226 1

The D<sub>2</sub> dopamine receptor (DRD2) is one of the most well-established therapeutic targets for neuropsychiatric and endocrine disorders. Most clinically approved and investigational drugs that target this receptor are known to be subfamily-selective for all three D<sub>2</sub>-like receptors, rather than subtype-selective for only DRD2. Here, we report the crystal structure of DRD2 bound to the most commonly used antipsychotic drug, haloperidol. The structures suggest an extended binding  ...[more]

Similar Datasets

Unknown Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870.
| S-EPMC6872212 | biostudies-literature
Unknown Structure-based evolution of subtype-selective neurotensin receptor ligands.
| S-EPMC4234217 | biostudies-literature
Unknown Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods.
| S-EPMC4022043 | biostudies-literature
Unknown Critical evaluation of a crystal structure of nitrogenase with bound N<sub>2</sub> ligands.
| S-EPMC8068654 | biostudies-literature
Unknown Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D<sub>3</sub> Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders.
| S-EPMC8498988 | biostudies-literature
Unknown Evaluation of Substituted <i>N</i>-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands.
| S-EPMC8198181 | biostudies-literature
Unknown Potent and Subtype-Selective Dopamine D<sub>2</sub> Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach.
| S-EPMC8552448 | biostudies-literature
Unknown Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D<sub>3</sub> Dopamine Receptor Agonist.
| S-EPMC7262777 | biostudies-literature
Unknown Fluorescent ligands for dopamine D<sub>2</sub>/D<sub>3</sub> receptors.
| S-EPMC7736868 | biostudies-literature
Unknown A two-step target binding and selectivity support vector machines approach for virtual screening of dopamine receptor subtype-selective ligands.
| S-EPMC3376116 | biostudies-literature